Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 6, 2012 - Issue 3
Submit an article Journal homepage
326
Views
25
CrossRef citations to date
0
Altmetric
Review

Efficacy of anticholinergic drugs in asthma

Federica Novelli Cardio-Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
,
Laura Malagrinò Cardio-Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
,
Federico L Dente Cardio-Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
&
Pierluigi Paggiaro Cardio-Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy. [email protected]
Pages 309-319 | Published online: 09 Jan 2014

References

  • Belmonte KE. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2(4), 297–304 (2005).
  • Lewis MJ, Short AL, Lewis KE. Autonomic nervous system control of the cardiovascular and respiratory systems in asthma. Respir. Med. 100(10), 1688–1705 (2006).
  • Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu. Rev. Med. 35, 451–467 (1984).
  • Sheppard D, Epstein J, Skoogh BE, Bethel RA, Nadel JA, Boushey HA. Variable inhibition of histamine-induced bronchoconstriction by atropine in subjects with asthma. J. Allergy Clin. Immunol. 73(1 Pt 1), 82–87 (1984).
  • Fabbri LM, Hendrick DJ, Diem JE. Effect of atropine on the bronchial response of asthmatic subjects to the inhalation of ultrasonically nebulized distilled water. J. Allergy Clin. Immunol. 71(5), 468–472 (1983).
  • Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA. Dose-dependent inhibition of cold air-induced bronchoconstriction by atropine. J. Appl. Physiol. 53(1), 169–174 (1982).
  • Fish JE, Rosenthal RR, Summer WR, Menkes H, Norman PS, Permutt S. The effect of atropine on acute antigen-mediated airway constriction in subjects with allergic asthma. Am. Rev. Respir. Dis. 115(3), 371–379 (1977).
  • Ruffin RE, Cockcroft DW, Hargreave FE. A comparison of the protective effect of fenoterol and Sch 1000 on allergen-induced asthma. J. Allergy Clin. Immunol. 61(1), 42–47 (1978).
  • Cockcroft DW, Ruffin RE, Hargreave FE. Effect of Sch1000 in allergen-induced asthma. Clin. Allergy 8(4), 361–372 (1978).
  • Paggiaro P, Bacci E, Talini D et al. Atropine does not inhibit late asthmatic responses induced by toluene-diisocyanate in sensitized subjects. Am. Rev. Respir. Dis. 136(5), 1237–1241 (1987).
  • Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60(9), 740–746 (2005).
  • Petrie GR, Palmer KN. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br. Med. J. 1(5955), 430–432 (1975).
  • Ruffin RE, Fitzgerald JD, Rebuck AS. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J. Allergy Clin. Immunol. 59(2), 136–141 (1977).
  • Thiessen B, Pedersen OF. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide. Respiration. 43(4), 304–316 (1982).
  • Jindal SK, Kaur SJ. Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma. Respiration 56(1–2), 16–21 (1989).
  • Boulet LP, Turcotte H, Tennina S. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges. J. Allergy Clin. Immunol. 83(5), 882–887 (1989).
  • Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur. Respir. J. 4(4), 415–420 (1991).
  • Chhabra SK, Pandey KK. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. J. Asthma 39(5), 375–381 (2002).
  • Delpierre S, Guillot C, Badier M. Same efficacies of ipratropium and salbutamol in reversing methacholine-induced bronchoconstriction. J. Asthma 43(9), 679–685 (2006).
  • Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulm. Pharmacol. Ther. 21(4), 630–636 (2008).
  • Ahmad Z, Singh SK. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics. J. Asthma 47(3), 340–343 (2010).
  • Cox ID, Hughes DT, McDonnell KA. Ipratropium bromide in patients with nocturnal asthma. Postgrad. Med. J. 60(706), 526–528 (1984).
  • Haney S, Hancox RJ. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomized controlled trials. Respire Res. 6, 8–19 (2007).
  • Tashkin DP, Celli B, Senn S et al.; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359(15), 1543–1554 (2008).
  • Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir. Med. 102(1), 50–56 (2008).
  • Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir. Med. 101(6), 1218–1228 (2007).
  • Kerstjens HA, Disse B, Schröder-Babo W et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J. Allergy Clin. Immunol. 128(2), 308–314 (2011).
  • Peters SP, Kunselman SJ, Icitovic N et al.; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 363(18), 1715–1726 (2010).
  • Wechsler ME, Lehman E, Lazarus SC et al.; National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Beta-adrenergic receptor polymorphisms and response to salmeterol. Am. J. Respir. Crit. Care Med. 173(5), 519–526 (2006).
  • Park HW, Yang MS, Park CS et al. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy 64(5), 778–783 (2009).
  • Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J. Allergy Clin. Immunol. 128(2), 315–322 (2011).
  • Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 370(9605), 2118–2125 (2007).
  • Bleecker ER, Nelson HS, Kraft M et al. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am. J. Respir. Crit. Care Med. 181(7), 676–687 (2010).
  • Iwamoto H, Yokoyama A, Shiota N et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur. Respir. J. 31(6), 1379–1380 (2008).
  • Hardin M, Silverman EK, Barr RG et al.; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir. Res. 12, 127 (2011).
  • Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur. Respir. J. 30(3), 452–456 (2007).
  • Pauwels RA, Löfdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N. Engl. J. Med. 337(20), 1405–1411 (1997).
  • Bateman ED, Rennard S, Barnes PJ et al. Alternative mechanisms for tiotropium. Pulm. Pharmacol. Ther. 22(6), 533–542 (2009).
  • Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc. Am. Thorac. Soc. 6(3), 256–259 (2009).
  • van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59(8), 713–721 (2004).
  • Verbanck S, Schuermans D, Vincken W. Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide. Int. J. Chron. Obstruct. Pulmon. Dis. 2(4), 625–634 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.